News
32co raises £2.2m in funding round
Published
5 months agoon


Health tech company 32Co has secured $3 million (£2.2 million) in seed funding in a round led by Balderton Capital.
The funding, which includes participation from Wavemaker Three-Sixty Health and strategic angels, will fuel the development of 32Co’s clinical collaboration platform with AI and prepare to build on new clinical use cases.
32Co aims to revolutionise access to specialised healthcare services by connecting general clinicians with a network of specialists.
The company’s platform enables patients to access a range of specialist advice and clinical services through their trusted local provider, without the travel, waiting times and often high fees.
Company founder and CEO, Dr Sonia Szamocki, said: “By connecting clinicians with different but complementary skill sets using technology, not only do more patients get access to the treatment they need, but clinicians feel less isolated and more fulfilled in their work.
“We see applications for this model in several healthcare specialities with a market size of over $500bn.
“We’re delighted to have the belief of Balderton and their experience and support will be integral as we scale 32Co.”
By facilitating collaboration between generalist and specialist clinicians, 32Co aims to offer patients the best of both worlds—high-quality clinical care delivered conveniently through their local provider.
The model scales specialist expertise beyond the confines of a single clinic, instantly generating additional supply through a network of generalist colleagues who already have existing patient relationships.
This creates new revenue streams for both generalist and specialist clinicians, while simultaneously increasing patient access to specialised services.
Specialist orthodontist, Dr Farmahan, said:
“I love this model. I can work from anywhere through the platform, it’s additional income and I enjoy mentoring colleagues.
“It’s great to see the progression colleagues make through this mentorship; producing safe and predictable results for our patients”.
Magda Lukaszewicz, Principal at Balderton, said: “We are proud to have partnered with 32co at the start of their journey.
“Having a number of health tech companies target patients directly – a lot fewer have managed to bring technology platforms to the hands of healthcare professionals, and collaboration between general practitioners and specialists is unlocking a completely new supply & demand – in an overwhelmed healthcare system.”
60
SHARES


Microsoft invests £2.5 billion in UK AI


TMS shows promise in tackling depression ‘epidemic’


AI depression app set for NHS clinical trial


UK Biobank releases world’s largest single set of sequencing data


Listen: Longevity, Eastern wisdom and Western science


Fundamental principles of healthcare digital twins


Tackling the diagnostic testing sustainability problem


Gym-going men ‘unaware’ of protein risk to fertility


Anti-choke mug protects Parkinson’s patients


AI model predicts breast cancer risk without racial bias
Sign up for free updates from Health Tech World
Trending stories
- Diagnostics3 weeks ago
3D model will advance understanding of spinal injury pathology
- Opinion7 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- AI3 weeks ago
AI can help predict survival outcomes for cancer patients
- Research4 days ago
Tackling the diagnostic testing sustainability problem